steap3
Overview
STEAP3 (six-transmembrane epithelial antigen of the prostate 3) is a metalloreductase enzyme encoded by the STEAP3 gene located on chromosome 12. This transmembrane protein belongs to the STEAP family of ferric reductases and plays a critical role in iron homeostasis by catalyzing the reduction of ferric iron (Fe³⁺) to ferrous iron (Fe²⁺), a form that can be transported across cellular membranes. STEAP3 is predominantly expressed in hematopoietic cells, immune cells, and various neuronal populations, making it particularly relevant to the iron dysregulation observed in neurodegenerative diseases. The protein contains multiple functional domains including transmembrane regions, a cytochrome b561-like domain, and NADPH-binding sites essential for its enzymatic activity.
Function and Biology
STEAP3 functions as a ferric reductase localized to endosomal and plasma membranes, where it reduces extracellular and intracellular ferric iron to ferrous iron. This reduction step is essential for iron uptake, particularly through the divalent metal transporter DMT1 (SLC11A2), which specifically recognizes ferrous iron. The enzyme requires NADPH as a cofactor and electrons derived from the electron transport chain to generate reactive oxygen species (ROS) as a byproduct of its enzymatic activity.
...steap3
Overview
STEAP3 (six-transmembrane epithelial antigen of the prostate 3) is a metalloreductase enzyme encoded by the STEAP3 gene located on chromosome 12. This transmembrane protein belongs to the STEAP family of ferric reductases and plays a critical role in iron homeostasis by catalyzing the reduction of ferric iron (Fe³⁺) to ferrous iron (Fe²⁺), a form that can be transported across cellular membranes. STEAP3 is predominantly expressed in hematopoietic cells, immune cells, and various neuronal populations, making it particularly relevant to the iron dysregulation observed in neurodegenerative diseases. The protein contains multiple functional domains including transmembrane regions, a cytochrome b561-like domain, and NADPH-binding sites essential for its enzymatic activity.
Function and Biology
STEAP3 functions as a ferric reductase localized to endosomal and plasma membranes, where it reduces extracellular and intracellular ferric iron to ferrous iron. This reduction step is essential for iron uptake, particularly through the divalent metal transporter DMT1 (SLC11A2), which specifically recognizes ferrous iron. The enzyme requires NADPH as a cofactor and electrons derived from the electron transport chain to generate reactive oxygen species (ROS) as a byproduct of its enzymatic activity.
In non-neuronal cells, STEAP3 is well-characterized for its role in erythropoiesis and immune cell function. Mutations in STEAP3 cause iron-refractory iron deficiency anemia, demonstrating its critical importance in systemic iron metabolism. However, recent evidence reveals STEAP3 expression in microglia, neurons, and astrocytes, suggesting broader roles in central nervous system iron handling.
STEAP3 is regulated by iron status through iron-responsive elements (IREs) in its mRNA, allowing cells to modulate protein expression based on intracellular iron levels. Hypoxia-inducible factors (HIFs) and other transcriptional regulators also influence STEAP3 expression in response to metabolic stress.
Role in Neurodegeneration
Iron accumulation in the brain is a hallmark feature of multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and frontotemporal dementia. Dysregulation of iron metabolism disrupts cellular iron homeostasis and exacerbates oxidative stress—a central mechanism in neuronal loss. STEAP3 dysfunction may contribute to pathological iron accumulation or, conversely, iron depletion in specific neuronal compartments.
In Parkinson's disease, substantia nigra neurons accumulate iron, contributing to dopaminergic neuronal death through increased ROS production and ferroptosis. Altered STEAP3 expression or activity could dysregulate ferric-to-ferrous iron conversion, affecting both iron transport into neurons and sequestration within iron storage proteins like ferritin. Similarly, in Alzheimer's disease, iron-catalyzed oxidative damage promotes amyloid-beta aggregation and tau pathology.
STEAP3's role in microglial iron metabolism is particularly significant, as activated microglia in neuroinflammatory conditions require iron for cytokine production and phagocytosis. Dysregulated STEAP3 in microglia could alter neuroinflammatory responses and contribute to neuronal damage through iron-dependent mechanisms.
Molecular Mechanisms
STEAP3 operates at the intersection of iron metabolism, redox signaling, and ferroptosis pathways. The protein's ferric reductase activity generates superoxide anions, which contribute to the oxidative microenvironment within endosomes and at the cell surface. This ROS generation, while necessary for iron reduction, can be pathologically elevated under neurodegenenerative conditions.
STEAP3 interacts with ferroportin (SLC40A1), the primary iron exporter, to establish directional iron flux across membranes. Dysfunction in this STEAP3-ferroportin axis impairs iron recycling and cellular iron balance. Additionally, STEAP3 may modulate ferroptosis sensitivity through its effects on intracellular ferrous iron pools, as ferroptosis is iron-dependent and sensitive to changes in labile iron concentrations.
Clinical and Research Significance
STEAP3 represents an emerging therapeutic target for iron-related neurodegeneration. Modulating STEAP3 activity could potentially normalize brain iron levels and reduce oxidative stress in conditions like Parkinson's disease and Alzheimer's disease. Research investigating STEAP3 expression in affected brain regions of neurodegenerative disease patients remains limited but growing.
Genetic variants in STEAP3 and polymorphisms affecting expression or enzyme kinetics warrant investigation as risk factors for neurodegeneration. Understanding how STEAP3 dysregulation intersects with other iron-related proteins and oxidative stress pathways is crucial for developing disease-modifying therapies.
- DMT1 (SLC11A2): Iron transporter dependent on STEAP3-mediated reduction
- Ferroportin (SLC40A1): Iron exporter working
Pathway Diagram
The following diagram shows the key molecular relationships involving steap3 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)